Firdapse (amifampridine phosphate)

pCPA File Number: 21919
Negotiation Status:
Concluded with an LOI
Indication(s):
Lambert-Eaton Myasthenic Syndrome (LEMS)
Sponsor/Manufacturer:
KYE Pharmaceuticals Inc.
CDA-AMC Project Number:
SR0664
pCPA Engagement Letter Issued:
Negotiation Process Concluded: